Dow Jones

39,118.86

-0.12%

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

MTP

Midatech Pharma (MTP)

Midatech Pharma PLC

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:MTP

1 2 3 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
24/06/2024	07:46	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:MTP	Midatech Pharma PLC
17/06/2024	05:00	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:MTP	Midatech Pharma PLC
16/06/2024	23:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:MTP	Midatech Pharma PLC
06/06/2024	15:05	Edgar (US Regulatory)	Form F-1 - Registration statement for certain foreign private issuers	NASDAQ:MTP	Midatech Pharma PLC
29/04/2024	20:55	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:MTP	Midatech Pharma PLC
14/02/2024	19:47	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:MTP	Midatech Pharma PLC
12/02/2024	15:30	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:MTP	Midatech Pharma PLC
20/12/2023	15:54	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:MTP	Midatech Pharma PLC
14/12/2023	16:20	Edgar (US Regulatory)	Form F-1/A - Registration statement for certain foreign private issuers: [Amend]	NASDAQ:MTP	Midatech Pharma PLC
07/12/2023	15:15	Edgar (US Regulatory)	Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses	NASDAQ:MTP	Midatech Pharma PLC
29/06/2023	05:05	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:MTP	Midatech Pharma PLC
28/06/2023	15:53	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:MTP	Midatech Pharma PLC
22/06/2023	15:34	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:MTP	Midatech Pharma PLC
20/06/2023	15:31	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:MTP	Midatech Pharma PLC
16/06/2023	07:42	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-1)	NASDAQ:MTP	Midatech Pharma PLC
07/06/2023	05:02	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	NASDAQ:MTP	Midatech Pharma PLC
26/05/2023	05:03	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:MTP	Midatech Pharma PLC
26/05/2023	05:03	Edgar (US Regulatory)	Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)	NASDAQ:MTP	Midatech Pharma PLC
06/03/2023	08:08	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:MTP	Midatech Pharma PLC
11/01/2023	16:05	GlobeNewswire Inc.	Bioasis Technologies Inc. Mails Management Information Circular for Annual and Special Meeting of Securityholders	NASDAQ:MTP	Midatech Pharma PLC
19/12/2022	06:47	GlobeNewswire Inc.	Bioasis Technologies Inc. Announces Amendments to Arrangement Agreement with Midatech Pharma plc	NASDAQ:MTP	Midatech Pharma PLC
13/12/2022	11:29	GlobeNewswire Inc.	Bioasis Technologies Inc. Announces Merger with Midatech Pharma plc	NASDAQ:MTP	Midatech Pharma PLC
18/10/2022	15:17	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-3)	NASDAQ:MTP	Midatech Pharma PLC
26/05/2022	15:20	Edgar (US Regulatory)	Specialized Disclosure Report (sd)	NASDAQ:MTP	Midatech Pharma PLC
26/04/2022	06:23	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:MTP	Midatech Pharma PLC
30/04/2021	15:06	Edgar (US Regulatory)	Amended Securities Registration (section 12(b)) (8-a12b/a)	NASDAQ:MTP	Midatech Pharma PLC
14/08/2020	06:07	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:MTP	Midatech Pharma PLC
11/08/2020	15:01	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-1/a)	NASDAQ:MTP	Midatech Pharma PLC
10/07/2020	09:49	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:MTP	Midatech Pharma PLC
17/06/2020	15:30	Edgar (US Regulatory)	Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)	NASDAQ:MTP	Midatech Pharma PLC